Scorpius Holdings
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch SCPX and buy or sell other stocks, ETFs, and their options commission-free!About SCPX
Scorpius Holdings, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company's T-cell activating platform (TCAP) produces therapies designed to turn immunologically cold tumors to hot, and be administered in combination with checkpoint inhibitors and other immuno-modulators to increase clinical effectiveness.
CEOJeff A. Wolf, MBA
CEOJeff A. Wolf, MBA
Employees84
Employees84
HeadquartersMorrisville, North Carolina
HeadquartersMorrisville, North Carolina
Founded2008
Founded2008
Employees84
Employees84
SCPX Key Statistics
Market cap234.21
Market cap234.21
Price-Earnings ratio-0.02
Price-Earnings ratio-0.02
Dividend yield—
Dividend yield—
Average volume13.08K
Average volume13.08K
High today$0.0013
High today$0.0013
Low today$0.0002
Low today$0.0002
Open price$0.0002
Open price$0.0002
Volume2.32K
Volume2.32K
52 Week high$146.00
52 Week high$146.00
52 Week low$0.0002
52 Week low$0.0002
Stock Snapshot
With a market cap of 234.21, Scorpius Holdings(SCPX) trades at $0.00. The stock has a price-to-earnings ratio of -0.02.
On 2026-06-01, Scorpius Holdings(SCPX) stock traded between a low of $0.00 and a high of $0.00. Shares are currently priced at $0.00, which is +550.0% above the low and 0.0% below the high.
Scorpius Holdings(SCPX) shares are trading with a volume of 2.32K, against a daily average of 13.08K.
During the past year, Scorpius Holdings(SCPX) stock moved between $0.00 at its lowest and $146.00 at its peak.
During the past year, Scorpius Holdings(SCPX) stock moved between $0.00 at its lowest and $146.00 at its peak.
People also own
Based on the portfolios of people who own SCPX. This list is generated using Robinhood data, and it’s not a recommendation.